NASDAQ:STLN | Profit Breakdown | Starling Oncology, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$161.28M-$4.62M-$9.79M-$9.79M
2026-03-31$147.44M-$6.51M-$2.49M-$2.49M
2025-12-31$141.96M-$6.91M-$7.51M-$7.51M
2025-09-30$136.56M-$8.05M-$16.5M-$16.5M
2025-06-30$119.8M-$11.21M-$17.14M-$17.01M
2025-03-31$104.41M-$9.91M-$19.59M-$19.59M
2024-12-31$100.27M-$11.93M-$13.18M-$13.18M
2024-09-30$99.9M-$13.85M-$16.11M-$16.11M
2024-06-30$98.58M-$16.36M-$15.48M-$15.48M
2024-03-31$94.67M-$17.97M-$19.89M-$19.89M
2023-12-31$85.79M-$15.29M-$19.07M-$18.75M
2023-09-30$82.04M-$13.93M-$17.28M-$17.42M
2023-06-30$80.22M-$14.94M-$16.8M-$16.9M
2023-03-31$76.19M-$32.87M-$29.95M-$30M
2022-12-31$71.42M-$25.08M-$11.37M-$11.01M
2022-09-30$64.98M-$20.1M-$2.7M-$2.67M
2022-06-30$60.92M-$18.3M-$5.49M-$5.45M
2022-03-31$55.16M-$18.47M$19.47M$19.29M
2021-12-31$52.3M-$40.83M-$12.62M-$10.16M
2021-09-30$52.28M-$2.16M-$2.18M-$2.98M
2021-06-30$49.84M-$1.12M$3.99M$3.21M
2021-03-31$48.58M-$1.75M-$778,000.00-$996,000.00
2020-12-31-$7.72M-$9.02M-$8.51M
2020-09-30-$198,480.00-$2.4M-$2.42M
2020-06-30-$194,558.00-$2.62M-$2.62M
2020-03-31-$87,774.00-$776,839.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$502.73M-$36.08M-$60.74M-$60.61M
2024-12-31$393.41M-$60.12M-$64.66M-$64.66M
2023-12-31$324.24M-$77.02M-$83.1M-$83.07M
2022-12-31$252.48M-$81.95M-$91,000.00$152,000.00
2021-12-31$203M-$45.86M-$11.6M-$10.93M
2020-12-31$187.52M-$8.2M-$14.82M-$14.32M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.